title: Production of IVF transgene-expressing bovine embryos using a novel strategy based on cell cycle inhibitors.
abstract: The objective was to evaluate the effects of cell cycle inhibitors (6-dimethylaminopurine [DMAP], and dehydroleukodine [DhL]) on transgene expression efficiency and on mosaic expression patterns of IVF bovine zygotes cytoplasmically injected with oolema vesicles coincubated with transgene. The DNA damage induced by the transgene or cell cycle inhibitors was measured by detection of phosphorylated histone H2AX foci presence (marker of DNA double-stranded breaks). Cloning of egfp blastomeres was included to determine continuity of expression after additional rounds of cellular division. The pCX-EGFP [enhanced green fluorescent protein gene (EGFP) under the chimeric cytomegalovirus IE-chicken-β-actin enhancer promoter control] gene plasmid (50 ng/μL) was injected alone (linear or circular exogenous DNA, leDNA and ceDNA, respectively) or associated with ooplasmic vesicles (leDNA-v or ceDNA-v). The effects of 2 mm DMAP or 1 μm DhL for 6 h (from 15 to 21 h post IVF) was evaluated for groups injected with vesicles. The DMAP increased (P < 0.05) egfp homogenous expression relative to transgene alone (21%, 18%, and 11% for leDNA-v + DMAP, leDNA-v, and leDNA, respectively) and also increased (P < 0.05) the phosphorylated histone H2AX foci area. Expression of egfp was higher (P < 0.05) for linear than for circular pCX-EGFP, and egfp blastocyst rates were higher (P < 0.05) for groups injected with linear transgene coincubated with vesicles than for linear transgene alone (95%, 77%, 84%, and 52% for leDNA-v + DMAP, leDNA-v + DhL, leDNA-v, and leDNA, respectively). Moreover, DMAP tended to improve egfp blastocysts rates for both circular and linear transgenes. Based on fluorescent in situ hybridization (FISH) analysis, there was evidence of integration in egfp embryos. Finally, clones derived from leDNA-v + DMAP had the highest egfp expression rates (96%, 65%, and 65% for leDNA-v + DMAP, leDNA-v, and leDNA, respectively). Transgenesis by cytoplasmic injection of leDNA-v + DMAP is a promising alternative for transgenic animal production.
authors.affiliation: Laboratorio de Biotecnología Animal, University of Buenos Aires, Buenos Aires, Argentina.
authors.forename: R J
authors.initials: RJ
authors.lastname: Bevacqua
authors.forename: F
authors.initials: F
authors.lastname: Pereyra-Bonnet
authors.forename: R
authors.initials: R
authors.lastname: Olivera
authors.forename: M I
authors.initials: MI
authors.lastname: Hiriart
authors.forename: P
authors.initials: P
authors.lastname: Sipowicz
authors.forename: R
authors.initials: R
authors.lastname: Fernandez-Martín
authors.forename: M
authors.initials: M
authors.lastname: Radrizzani
authors.forename: D F
authors.initials: DF
authors.lastname: Salamone
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D030801:Animals, Genetically Modified; D002417:Cattle / Q000196:embryology* / Q000235:genetics; D002453:Cell Cycle / Q000187:drug effects; D018797:Cell Cycle Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics; D019976:Cloning, Organism / Q000379:methods*; D046149:Embryo Culture Techniques / Q000379:methods; D004622:Embryo, Mammalian; D005260:Female; D005307:Fertilization in Vitro / Q000187:drug effects / Q000662:veterinary; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects; D007783:Lactones / Q000494:pharmacology; D008297:Male; D047428:Protein Kinase Inhibitors / Q000494:pharmacology*; D012717:Sesquiterpenes / Q000494:pharmacology; D019076:Transgenes / Q000235:genetics
chemical_list: D018797:Cell Cycle Proteins; D007783:Lactones; D047428:Protein Kinase Inhibitors; D012717:Sesquiterpenes; C079949:dehydroleucodine; C001020:N(6),N(6)-dimethyladenine; D000225:Adenine